Literature DB >> 25267616

Vasoprotective effect of PDGF-CC mediated by HMOX1 rescues retinal degeneration.

Chang He1, Chen Zhao2, Anil Kumar1, Chunsik Lee1, Mingquan Chen1, Lijuan Huang1, Jing Wang1, Xiangrong Ren1, Yida Jiang1, Wei Chen1, Bin Wang3, Zhiqin Gao4, Zheng Zhong1, Zijing Huang1, Fan Zhang1, Bing Huang1, Hao Ding5, Rong Ju1, Zhongshu Tang1, Yizhi Liu1, Yihai Cao6, Xuri Li7, Xialin Liu7.   

Abstract

Blood vessel degeneration is critically involved in nearly all types of degenerative diseases. Therefore strategies to enhance blood vessel protection and survival are highly needed. In this study, using different animal models and cultured cells, we show that PDGF-CC is a potent vascular protective and survival factor. PDGF-CC deficiency by genetic deletion exacerbated blood vessel regression/degeneration in various animal models. Importantly, treatment with PDGF-CC protein not only increased the survival of retinal blood vessels in a model of oxygen-induced blood vessel regression but also markedly rescued retinal and blood vessel degeneration in a disease model of retinitis pigmentosa. Mechanistically, we revealed that heme oxygenase-1 (HMOX1) activity is critically required for the vascular protective/survival effect of PDGF-CC, because blockade of HMOX1 completely abolished the protective effect of PDGF-CC in vitro and in vivo. We further found that both PDGF receptors, PDGFR-β and PDGFR-α, are required for the vasoprotective effect of PDGF-CC. Thus our data show that PDGF-CC plays a pivotal role in maintaining blood vessel survival and may be of therapeutic value in treating various types of degenerative diseases.

Entities:  

Keywords:  HMOX1; PDGF-CC; blood vessel regression; retinal degeneration; vasoprotective effect

Mesh:

Substances:

Year:  2014        PMID: 25267616      PMCID: PMC4205610          DOI: 10.1073/pnas.1404140111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets.

Authors:  Xu Hou; Anil Kumar; Chunsik Lee; Bin Wang; Pachiappan Arjunan; Lijin Dong; Arvydas Maminishkis; Zhongshu Tang; Yang Li; Fan Zhang; Shi-Zhuang Zhang; Piotr Wardega; Sagarika Chakrabarty; Baoying Liu; Zhijian Wu; Peter Colosi; Robert N Fariss; Johan Lennartsson; Robert Nussenblatt; J Silvio Gutkind; Yihai Cao; Xuri Li
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

2.  Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy.

Authors:  Napoleone Ferrara
Journal:  Nat Med       Date:  2010-10       Impact factor: 53.440

3.  High level expression of angiopoietin-2 in human abscesses.

Authors:  Cynthia Bartus; Lawrence F Brown; Michael Y Bonner; Jack L Arbiser
Journal:  J Am Acad Dermatol       Date:  2011-01       Impact factor: 11.527

Review 4.  Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait.

Authors:  Alan F Wright; Christina F Chakarova; Mai M Abd El-Aziz; Shomi S Bhattacharya
Journal:  Nat Rev Genet       Date:  2010-04       Impact factor: 53.242

Review 5.  Mechanisms of cell protection by heme oxygenase-1.

Authors:  Raffaella Gozzelino; Viktoria Jeney; Miguel P Soares
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

6.  Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3beta phosphorylation.

Authors:  Zhongshu Tang; Pachiappan Arjunan; Chunsik Lee; Yang Li; Anil Kumar; Xu Hou; Bin Wang; Piotr Wardega; Fan Zhang; Lijin Dong; Yongqing Zhang; Shi-Zhuang Zhang; Hao Ding; Robert N Fariss; Kevin G Becker; Johan Lennartsson; Nobuo Nagai; Yihai Cao; Xuri Li
Journal:  J Exp Med       Date:  2010-03-15       Impact factor: 14.307

7.  VEGF-independent angiogenic pathways induced by PDGF-C.

Authors:  Xuri Li; Anil Kumar; Fan Zhang; Chunsik Lee; Yang Li; Zhongshu Tang; Pachiappan Arjuna
Journal:  Oncotarget       Date:  2010-08

8.  PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment.

Authors:  Yongping Crawford; Ian Kasman; Lanlan Yu; Cuiling Zhong; Xiumin Wu; Zora Modrusan; Josh Kaminker; Napoleone Ferrara
Journal:  Cancer Cell       Date:  2009-01-06       Impact factor: 31.743

9.  VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats.

Authors:  Yang Li; Fan Zhang; Nobuo Nagai; Zhongshu Tang; Shuihua Zhang; Pierre Scotney; Johan Lennartsson; Chaoyong Zhu; Yi Qu; Changge Fang; Jianyuan Hua; Osamu Matsuo; Guo-Hua Fong; Hao Ding; Yihai Cao; Kevin G Becker; Andrew Nash; Carl-Henrik Heldin; Xuri Li
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

10.  Platelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta.

Authors:  Fuwang Peng; Honghong Yao; Halis Kaan Akturk; Shilpa Buch
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

View more
  12 in total

Review 1.  PDGF/PDGFR axis in the neural systems.

Authors:  Susmita Sil; Palsamy Periyasamy; Annadurai Thangaraj; Ernest T Chivero; Shilpa Buch
Journal:  Mol Aspects Med       Date:  2018-02-06

2.  The role of myeloid cell-derived PDGF-B in neotissue formation in a tissue-engineered vascular graft.

Authors:  Ekene Onwuka; Cameron Best; Andrew Sawyer; Tai Yi; Eric Heuer; Malik Sams; Matthew Wiet; Hong Zheng; Themis Kyriakides; Christopher Breuer
Journal:  Regen Med       Date:  2017-05-19       Impact factor: 3.806

Review 3.  Vasoregression: A Shared Vascular Pathology Underlying Macrovascular And Microvascular Pathologies?

Authors:  Akanksha Gupta; Sonika Bhatnagar
Journal:  OMICS       Date:  2015-12

4.  PDGF-CC underlies resistance to VEGF-A inhibition and combinatorial targeting of both suppresses pathological angiogenesis more efficiently.

Authors:  Lei Zheng; Chen Zhao; Yuxiang Du; Xianchai Lin; Yida Jiang; Chunsik Lee; Geng Tian; Jia Mi; Xianglin Li; Qishan Chen; Zhimin Ye; Lijuan Huang; Shasha Wang; Xiangrong Ren; Liying Xing; Wei Chen; Delong Huang; Zhiqin Gao; Shuping Zhang; Weisi Lu; Zhongshu Tang; Bin Wang; Rong Ju; Xuri Li
Journal:  Oncotarget       Date:  2016-11-22

5.  Microglia Polarization with M1/M2 Phenotype Changes in rd1 Mouse Model of Retinal Degeneration.

Authors:  Tian Zhou; Zijing Huang; Xiaowei Sun; Xiaowei Zhu; Lingli Zhou; Mei Li; Bing Cheng; Xialin Liu; Chang He
Journal:  Front Neuroanat       Date:  2017-09-05       Impact factor: 3.856

6.  General Study and Gene Expression Profiling of Endotheliocytes Cultivated on Electrospun Materials.

Authors:  Alena O Stepanova; Petr P Laktionov; Anna V Cherepanova; Vera S Chernonosova; Georgiy Yu Shevelev; Ivan A Zaporozhchenko; Alexander M Karaskov; Pavel P Laktionov
Journal:  Materials (Basel)       Date:  2019-12-06       Impact factor: 3.623

7.  Hyperdry human amniotic membrane application as a wound dressing for a full-thickness skin excision after a third-degree burn injury.

Authors:  Jiro Oba; Motonori Okabe; Toshiko Yoshida; Chika Soko; Moustafa Fathy; Koji Amano; Daisuke Kobashi; Masahiro Wakasugi; Hiroshi Okudera
Journal:  Burns Trauma       Date:  2020-07-27

8.  TLR2/4 deficiency prevents oxygen-induced vascular degeneration and promotes revascularization by downregulating IL-17 in the retina.

Authors:  Chang He; Peilong Lai; Jing Wang; Tian Zhou; Zijing Huang; Lingli Zhou; Xialin Liu
Journal:  Sci Rep       Date:  2016-06-14       Impact factor: 4.379

9.  Co-option of pre-existing vascular beds in adipose tissue controls tumor growth rates and angiogenesis.

Authors:  Sharon Lim; Kayoko Hosaka; Masaki Nakamura; Yihai Cao
Journal:  Oncotarget       Date:  2016-06-21

10.  Bcl-6-directed follicular helper T cells promote vascular inflammatory injury in diabetic retinopathy.

Authors:  Yan Liu; Ziqi Yang; Peilong Lai; Zijing Huang; Xiaowei Sun; Tian Zhou; Chang He; Xialin Liu
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.